Platelet Rich Plasma as Monotherapy in Androgenetic Alopecia
September 2025
in “
Journal of Neonatal Surgery
”
New to Platelet-Rich Plasma? There is a guide in the encyclopedia. Read the guide → 
Studysummary This study found that platelet-rich plasma therapy significantly improved hair density and reduced hair loss in patients with androgenetic alopecia over six months, but lacks a comparative placebo or alternative treatment group.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
This pilot study investigated the effects of Platelet Rich Plasma (PRP) therapy as a monotherapy for androgenetic alopecia in a hospital setting, involving subjects aged 18-40 years with specific classifications of male and female pattern baldness. Over 6 months, PRP was prepared from the patients' blood and injected monthly into the alopecic areas. Results showed a significant reduction in hair loss, with the mean hair pull test score decreasing from 5.44 to 0.38, and an increase in hair density from 96.54 to 106.92/cm². The study concluded that PRP shows promise as a treatment for androgenetic alopecia, but highlighted the need for further research with comparative groups to better understand its efficacy.
